Adendra Therapeutics
Adendra Therapeutics develop treatments for cancers and autoimmune diseases by applying new insights into regulation of adaptive immune responses by dendritic cells
London, UKadendratx.com ↗
Total raised
€47M
€46,833,193
Funding rounds
1
Investors
1
distinct backers
Active since
2021-12
latest 2021-12
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood32
base rate 44% for Series A
- ▼ Overdue vs cohort gap
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-12-12 | Series A | €47M | ATP | View deal → |